158 related articles for article (PubMed ID: 37773704)
61. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha.
Kraman M; Bambrough PJ; Arnold JN; Roberts EW; Magiera L; Jones JO; Gopinathan A; Tuveson DA; Fearon DT
Science; 2010 Nov; 330(6005):827-30. PubMed ID: 21051638
[TBL] [Abstract][Full Text] [Related]
62. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Lee J; Fassnacht M; Nair S; Boczkowski D; Gilboa E
Cancer Res; 2005 Dec; 65(23):11156-63. PubMed ID: 16322266
[TBL] [Abstract][Full Text] [Related]
63. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
[TBL] [Abstract][Full Text] [Related]
64. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.
Wan Y; Emtage P; Zhu Q; Foley R; Pilon A; Roberts B; Gauldie J
Cell Immunol; 1999 Dec; 198(2):131-8. PubMed ID: 10648127
[TBL] [Abstract][Full Text] [Related]
65. FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.
Liu Y; Sun Y; Wang P; Li S; Dong Y; Zhou M; Shi B; Jiang H; Sun R; Li Z
J Transl Med; 2023 Apr; 21(1):255. PubMed ID: 37046312
[TBL] [Abstract][Full Text] [Related]
66. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
[TBL] [Abstract][Full Text] [Related]
67. Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.
Li H; Jiang HJ; Ma MQ; Wei F; An XM; Ren XB
Cancer Biother Radiopharm; 2007 Dec; 22(6):790-8. PubMed ID: 18158770
[TBL] [Abstract][Full Text] [Related]
68. High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma.
Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
Thorac Cancer; 2022 Aug; 13(16):2377-2384. PubMed ID: 35818720
[TBL] [Abstract][Full Text] [Related]
69. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
He Y; Zhang J; Mi Z; Robbins P; Falo LD
J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
[TBL] [Abstract][Full Text] [Related]
70. [Salidroside induces anti-tumor effect in dendritic cells via ERK pathway].
Zhang Y; Yue Q; Wen Z; Zhang X; Li P; Cui L; Zhang M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):979-985. PubMed ID: 31878993
[TBL] [Abstract][Full Text] [Related]
71. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
[TBL] [Abstract][Full Text] [Related]
72. In vitro antitumor cytotoxic T lymphocyte response induced by dendritic cells transduced with DeltaNp73alpha recombinant adenovirus.
Hu Y; He Y; Srivenugopal KS; Fan S; Jiang Y
Oncol Rep; 2007 Nov; 18(5):1085-91. PubMed ID: 17914557
[TBL] [Abstract][Full Text] [Related]
73. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.
Broder H; Anderson A; Odesa SK; Kremen TJ; Liau LM
Neurosurg Focus; 2000 Dec; 9(6):e6. PubMed ID: 16817689
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis.
Kim JO; Jung SS; Kim SY; Kim TY; Shin DW; Lee JH; Lee YH
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S38-46. PubMed ID: 17923753
[TBL] [Abstract][Full Text] [Related]
75. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
76. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
77. HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer.
Zhang Y; Bian Y; Wang Y; Wang Y; Duan X; Han Y; Zhang L; Wang F; Gu Z; Qin Z
J Cell Mol Med; 2021 Jun; 25(12):5457-5469. PubMed ID: 33943003
[TBL] [Abstract][Full Text] [Related]
78. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.
Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S
Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572
[TBL] [Abstract][Full Text] [Related]
79. Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo.
Peng W; Zhao G; Ma Y; Yu H; Wang X
Vaccine; 2011 Apr; 29(18):3501-6. PubMed ID: 21352943
[TBL] [Abstract][Full Text] [Related]
80. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
